Medicine
Atazanavir 300 mg capsule
Atazanavir 300 mg capsule is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store atazanavir capsules at 20° to 25°C (68° to 77°F), excursions permitted…
Key facts
- Active ingredient (INN)
- Atazanavir
- Brand
- Sold under the generic name
- Strength
- 300 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 3 blister pack, 500 capsules, 30 capsules and 7 more
- Manufacturers
- Aurobindo PharmaIndiaCamber PharmaceuticalsIndiaLaurus LabsIndiaTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store atazanavir capsules at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AE08 Atazanavir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 December 2017
- Identifiers
- RxCUI 402246, 402247, 664741 +1DailyMed set ID c98e40ec-8a2c-4f19-b1c3-c82f708c2490, 8a0c609f-e296-4925-a35c-e93a04467655, 7fbea274-d6b5-4faa-bbf0-05fefab42114 +1NDC 42385-922, 31722-655, 65862-713 +1Application ANDA212579, ANDA212278, ANDA204806 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 blister pack in 1 carton / 10 capsule in 1 blister pack | 65862-713-03 | Aurobindo PharmaIndia | 25 June 2018 |
| 500 capsule in 1 bottle | 65862-713-05 | Aurobindo PharmaIndia | 25 June 2018 |
| 30 capsule in 1 bottle | 65862-713-30 | Aurobindo PharmaIndia | 25 June 2018 |
| 90 capsule in 1 bottle | 65862-713-90 | Aurobindo PharmaIndia | 25 June 2018 |
| 500 capsule in 1 bottle | 31722-655-05 | Camber PharmaceuticalsIndia | 7 February 2022 |
| 30 capsule in 1 bottle | 31722-655-30 | Camber PharmaceuticalsIndia | 7 February 2022 |
| 100 blister pack in 1 carton / 10 capsule in 1 blister pack | 31722-655-31 | Camber PharmaceuticalsIndia | 7 February 2022 |
| 30 capsule in 1 bottle | 42385-922-30 | Laurus LabsIndia | 30 April 2021 |
| 5 blister pack in 1 carton / 6 capsule in 1 blister pack | 42385-922-37 | Laurus LabsIndia | 30 April 2021 |
| 30 capsule in 1 bottle | 0093-5528-56 | Teva Pharmaceuticals | 27 December 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Atazanavir 300 mg capsule.
Other strengths and forms of Atazanavir
Clinical summary
Atazanavir is a protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients 3 months and older weighing at least 5 kg, among other approved uses. MedsAcross supplies Atazanavir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AtazanavirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- REYATAZ prescribing information (ER Squibb & Sons) · U.S. National Library of Medicine, DailyMed
- Reyataz: European public assessment report (EPAR) · European Medicines Agency
- Atazanavir Viatris (previously Atazanavir Mylan): European public assessment report (EPAR) · European Medicines Agency
Need Atazanavir 300 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.